Abbott India Limited Share Price & Analysis
Price Chart
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,844 | ₹4.4L Cr | 36.5 | 5.69 | 16.9 | 20.2 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹6,711 | ₹1.8L Cr | 70.3 | 11.55 | 15.4 | 20.4 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹4,358 | ₹1.5L Cr | 64.3 | 17.43 | 26.5 | 27 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,057 | ₹1.2L Cr | 64.1 | 12.75 | 18.4 | 16.6 | 0.88 |
| CIPLA Cipla Limited | ₹1,306 | ₹1.1L Cr | 22.9 | 3.2 | 17.8 | 22.7 | 0.01 |
| LUPIN Lupin Limited | ₹2,238 | ₹1.1L Cr | 18.9 | 4.56 | 29.1 | 30.3 | 0.32 |
| DRREDDY Dr. Reddy's Laboratories Limited | ₹1,274 | ₹1.1L Cr | 19.4 | 2.95 | 18 | 22.7 | 0.16 |
Showing 7 peers in the same sector · Sorted by market cap
Latest News
All news →Abbott India rating and price target slashed by broker
*Abbott India rating and price target slashed by broker.* Weak growth outlook prompted a double downgrade from a broker, cutting share price expectations. The move reflects concerns over **slowing sales** and **margin pressures** in key segments. This could weigh on near-term investor sentiment. 📊 *STOCKS:* ABBOTINDIA | 🏢 *SECTOR:* Pharma | #MEDIUMIMPACT #broker-downgrade
Abbott India target, rating cut on weak growth
*Abbott India target, rating cut on weak growth* — Brokerage slashed Abbott India's stock price target and rating due to weak growth outlook. Revenue and earnings growth are expected to remain subdued. 📊 *STOCKS:* ABBOTINDIA | 🏢 *SECTOR:* Pharma | #MEDIUMIMPACT #BrokerDowngrade
JPMorgan cuts Abbott India target price; pharma stock downgrade
*JPMorgan cuts Abbott India target price in bearish call on pharma stock.* The downgrade reflects concerns over valuation and growth prospects for the pharmaceutical company. This broker call may trigger selling pressure among retail and institutional investors holding the stock. Monitor support levels for potential entry opportunities. 📊 *STOCKS:* $ABBOTINDIA | 🏢 *SECTOR:* Pharma | #MEDIUMIMPACT #broker_downgrade
Abbott India downgraded on weak growth outlook by broker
*Abbott India share price target and rating slashed on weak growth outlook.* Broker has issued a **double downgrade** citing concerns over the company's **growth trajectory**. This signals deteriorating sentiment among institutional analysts regarding Abbott India's near-term performance prospects. 📊 *STOCKS:* $ABBOTINDIA | 🏢 *SECTOR:* Pharma | #MEDIUMIMPACT #downgrade
About Abbott India Limited
Abbott India Ltd is one of the leading multinational pharmaceutical companies in India and sells its products through independent distributors primarily within India.[1] It was established in 1944.[2]
Healthcare · Healthcare